MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

DNMSQuest: a simple tool for identifying mood disorders in cervical dystonia?

S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)
DO FREEZING OF GAIT AND GAIT AUTOMATICITY IN PARKINSON’S DISEASE SHARE THE SIMILAR NEURAL SUBSTRATE?

F. de Almeida, C. Ugrinowitsch, M. Nucci, D. Coelho, A. Moreira-Neto, E. Barbosa, L. Teixeira, E. Amaro JR., F. Horak, M. Mancini, C. Silva-Batista (São Paulo, Brazil)
Do Parkinson’s disease medications have an effect on gut microbiome? A case-control study

P. Zhang, P. Huang, Y. Qian, X. Yang, Y. He, J. Du, G. Li, S. Cui, S. Xu, J. Liu, Y. Lin, Y. Fu, G. He, Z. Zhang, Q. Xiao, S. Chen (Shanghai, China)
Does cognition, depression and quality of life influence the balance of elderly with Parkinson’s disease ?.

L. Pereira, P. Broto, M. Terra, N. Barboza, H. Oliveira Araújo, M. Bueno, S. Smaili (Londrina, Brazil)
Does Macronutrient dietary Intake of patients with Parkinson disease correlates with the cognitive function (MoCA)?

C. López Botello, S. Castillo Torres, I. Estrada Bellmann, B. Chávez Luevanos (Monterrey, Mexico)
Does MDS-UPDRS provide greater sensitivity to mild disease than UPDRS for assessing motor severity in early Parkinson’s disease?

D. Hall, M. Tosin, C. Patterson, G. Stebbins (Chicago, USA)
Does Microneedle Use for Facial Injection of Botulinum Toxin Reduce Pain? A Systematic Literature Review

S. Maytharakcheep (Bangkok, Thailand)
Does neurodegeneration of the noradrenergic locus coeruleus follow a spatial gradient in Parkinson’s disease?

C. Madelung, D. Meder, S. Fuglsang, V. Boer, E. Petersen, A. Løkkegaard, H. Siebner (Hvidovre, Denmark)
Does the observation of an action inserted in an emotion-enriched context influence cortical excitability in patients with Parkinson’s disease?

G. Lagravinese, E. Pelosin, A. Bisio, G. Bonassi, M. Putzolu, A. Botta, C. Cosentino, C. Ponte, S. Mezzarobba, L. Avanzino (Genoa, Italy)
Dopamine dysregulation syndrome in Parkinson’s disease after COVID-19. Case report.

A. Nikitina, D. Degterev (Moscow, Russian Federation)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z